Miria Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Miria Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-323,528	Closed	-$37.3M	–	11
2023 Q3	$37.3M	Buy	323,528 +223,528	+224%	+$24M	31.95%	2
2023 Q2	$10.3M	Sell	100,000 -153,430	-61%	-$16.2M	26.45%	1
2023 Q1	$27.7M	Buy	+253,430	New	+$28M	56.09%	1

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Miria Asset Management's HZNP Position: Q4 2023 in Review

Miria Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 323,528 shares — an estimated $37.3M sold.

Miria Asset Management first reported a position in HZNP in Q1 2023 and held it in 3 quarters. The position peaked at $37.3M in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Miria Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Miria Asset Management sold 323,528 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $37.3M.
Miria Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023 and held it in 3 quarters.
Miria Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $37.3M in Q3 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Miria Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.